share_log

阜丰集团(00546.HK)中期股东溢利增长55.82%至人民币5.91亿元 派息9.8港仙

Medium-term shareholder profit of Fufeng Group (00546.HK) increased by 55.82% to pay out a dividend of HK9.8 cents of 591 million yuan.

財華社 ·  Aug 30, 2021 12:37

[Caihua News] Fufeng Group (00546.HK) announced that in the six months ended June 30, 2021, revenue was about 9.521 billion yuan, an increase of 16.55 percent over the same period last year. The profit attributable to shareholders was about 591 million yuan, an increase of 55.82% over the same period last year. Earnings per share are 23.33 cents; dividends per share are HK9.8 cents.

The increase in revenue was mainly due to an increase in the contribution of threonine, corn refined products, high-grade amino acids and monosodium glutamate compared with the same period in 2020.

From a product point of view, the company's main products, including monosodium glutamate and xanthan gum, respectively, are the largest manufacturers in the world, bringing stable cash flow to the group. On the other hand, the company's animal nutrition and high-grade amino acid products have brought a strong driving force for the group's growth.

For the six months ended June 30, 2021, the Group's gross profit margin increased to approximately RMB 1.766 billion, and the gross profit margin increased by 0.5% to 18.5%. The increase in gross profit contribution is mainly due to 1. 5%. Diversified product portfolio: excellent diversified product development layout, further expand the product line, establish the business structure of a number of core products, and enhance the core competitiveness of the Group. two。 A variety of driving forces for profit growth: 1) animal nutrition products bring a relatively large contribution to profits; 2) high-grade amino acid products are one of the main sources of profit during the period. The company continues to increase its market share and consolidate its leadership position in the amino acid industry, as well as to increase its product portfolio. The company also maintains flexible marketing and pricing strategies to expand its market share and consolidate its market position.

China has outstanding advantages in the effectiveness of epidemic prevention and control. Market conditions in China's recovery are relatively stable. However, there are differences in the pace of economic recovery in several economies because the economies concerned are still affected by the COVID-19 epidemic. The Group will closely monitor market conditions and adopt flexible marketing strategies to achieve stable growth.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment